Catalytic CEO Sean Chou explains the difference between process automation and robotic automation, as well as what it looks like to use automation to augment existing workflows. Importantly, he describes how manufacturers can use automation to do more with less—to lessen supply chain pressures that have grown because of globalization and the Covid-19 crisis. And he details which processes manufacturers can automate to optimize resources and productivity.
Demand for automation and robots is surging in multiple industries, including automotive, writes the CEO of Thomas.com.
An Eaton executive describes the automotive supplier's plans to utilize Industry 4.0.
John Deere’s Eric Johnson discusses the company’s additive manufacturing journey—with an eye toward helping small and medium businesses get going in AM. Learn about the early days of getting one of the first AM parts, as well as unrealistic expectations of the technology and how John Deere is creating value with the technology today. Finally, Johnson provides tips on unlocking the value of AM for your business in five key applications.
Take a break from the virtual and go live at the 32nd edition of BI-MU. Over 550 companies have confirmed their presence at this Italian trade show for machine tools, robotics and automation in Milan, Italy.
ExOne Company and Xometry announced they will join together to provide metal 3D printing services.
Maker of a new alloy targets extremely corrosive environments and seawater applications
David Tucker, automotive strategy and production development manager at HP 3D Printing, and Kyle Harvey, business unit manager for additive manufacturing at Extol, talk about HP’s recent announcement of polypropylene as a material for AM, as well as how Extol is involved in HP’s expansion of its 3D printing business.
With the potential for a 30% productivity increase or even more, there's a strong incentive for automating CNC machining processes. But before you flip the switch on that robot, you’ll need to check out the surrounding tools and processes.
Bioprinting is in the vanguard of the war against the novel coronavirus and holds promise for greater understanding of the way SAR-CoV-2 works in the human body.